Skip to main content
Clinical Trials/NCT01660217
NCT01660217CompletedNot Applicable

Eczema Action Plan Improves Patient and Caregiver Understanding and Perception of Atopic Dermatitis Management: A Randomized Controlled Trial

Dermatology & Aesthetics of Wicker Park1 site in 1 country37 target enrollmentStarted: June 1, 2011Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
37
Locations
1
Primary Endpoint
Participants understanding of atopic dermatitis and homecare regimen

Study Overview

Brief Summary

This is a randomized controlled study. The control group will consist of adult subjects and the caregivers of pediatric subjects with an established diagnosis of atopic dermatitis (AD), who are visiting a dermatologist for a standard AD office visit. In the control group, only verbal instruction (VI), the standard of care, will be provided. The intervention group will receive a similar VI with an additional component: an eczema education handout, as well as an individualized written Eczema Action Plan (EAP) that will illustrate how to recognize disease flare-ups and subsequent remissions. In addition, the EAP will provide detailed step-wise instructions regarding treatment modifications for the above-mentioned variations in treatment severity. To ensure that all patients ultimately receive the same level of care, the control group will also receive an EAP at the end of their consultation.

The goal of this study is to assess subjects' perception in the provider's use of an EAP and its effectiveness in helping patients understand their disease and management plan. In order to evaluate the primary end-points, subjects in both the control and treatment groups will be asked to complete post-consultation surveys. Four post-consultation outcomes will be measured: (1) caregivers' understanding of the disease and treatment, (2) caregivers' comfort level in following the EAP at home, (3) caregivers' anxiety level in managing the AD at home, and (4) caregivers' preference for VI + EAP as compared to VI alone, EAP alone, or neither the EAP nor the VI.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Crossover
Primary Purpose
Supportive Care
Masking
None

Eligibility Criteria

Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Age 18 or older fulfilling Hanifin and Rajka diagnostic criteria for AD, or adult caregivers for patients younger than 18 years of age, and the ability to comprehend study materials in English

Exclusion Criteria

  • •Prior exposure to written action plans

Arms & Interventions

Initial Verbal Instruction Group

Experimental

The group who initially received only verbal instruction, and then later (in the "crossover portion") received a written Eczema Action Plan (EAP)

Intervention: A written Eczema Action Plan (EAP) (Other)

Written Eczema Action Plan (EAP)

Experimental

The group given a written EAP after verbal instruction

Intervention: A written Eczema Action Plan (EAP) (Other)

Outcomes

Primary Outcomes

Participants understanding of atopic dermatitis and homecare regimen

Time Frame: At the beginning of the visit and at the end of the visit (approximately 45min later)

Secondary Outcomes

  • Changes in emotional distress level on disease self-management(At the beginning of the visit and at the end of the visit (approximately 45min later))

Investigators

Sponsor
Dermatology & Aesthetics of Wicker Park
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Peter A. Lio, MD

Attending Physician in Dermatology

Northwestern University

Study Sites (1)

Loading locations...

Similar Trials